West Pharmaceutical Services, Inc. (CH:WPS)
NYSE:WPS
Total Valuation
West Pharmaceutical Services has a market cap or net worth of CHF18.90B. The enterprise value is $22.60B.
Market CapCHF18.90B
Enterprise Value$22.60B
Share Statistics
West Pharmaceutical Services has ― shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding―
Owned by Insiders0.55%
Owned by Institutions30.30%
Financial Efficiency
West Pharmaceutical Services’s return on equity (ROE) is 0.16 and return on invested capital (ROIC) is 13.62%.
Return on Equity (ROE)0.16
Return on Assets (ROA)0.12
Return on Invested Capital (ROIC)13.62%
Return on Capital Employed (ROCE)0.17
Revenue Per Employee289.97K
Profits Per Employee46.58K
Employee Count10,600
Asset Turnover0.72
Inventory Turnover4.44
Valuation Ratios
The current PE Ratio of West Pharmaceutical Services is 44.4. West Pharmaceutical Services’s PEG ratio is 34.00.
PE Ratio44.4
PS Ratio6.47
PB Ratio6.26
Price to Fair Value6.26
Price to FCF42.42
Price to Operating Cash Flow33.69
PEG Ratio34.00
Income Statement
In the last 12 months, West Pharmaceutical Services had revenue of 3.07B and earned 493.70M in profits. Earnings per share was 6.83.
Revenue3.07B
Gross Profit1.10B
Operating Income617.40M
Pretax Income615.30M
Net Income493.70M
EBITDA723.60M
Earnings Per Share (EPS)6.83
Cash Flow
In the last 12 months, operating cash flow was 715.30M and capital expenditures -257.30M, giving a free cash flow of 458.00M billion.
Operating Cash Flow715.30M
Free Cash Flow458.00M
Free Cash Flow per Share10.00T>
Dividends & Yields
West Pharmaceutical Services pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta―
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
West Pharmaceutical Services upcoming earnings date is Jul 23, 2026, Before Open (Confirmed).
Last Earnings DateApr 23, 2026
Next Earnings DateJul 23, 2026
Ex-Dividend Date―
Financial Position
West Pharmaceutical Services as a current ratio of 3.02, with Debt / Equity ratio of 10.57%
Current Ratio3.02
Quick Ratio2.34
Debt to Market Cap0.02
Net Debt to EBITDA-0.52
Interest Coverage Ratio1.03K
Taxes
In the past 12 months, West Pharmaceutical Services has paid 121.60M in taxes.
Income Tax121.60M
Effective Tax Rate0.20
Enterprise Valuation
West Pharmaceutical Services EV to EBITDA ratio is 26.97, with an EV/FCF ratio of 41.63.
EV to Sales6.35
EV to EBITDA26.97
EV to Free Cash Flow41.63
EV to Operating Cash Flow25.86
Balance Sheet
West Pharmaceutical Services has CHF521.40M in cash and marketable securities with CHF316.20M in debt, giving a net cash position of CHF205.20M billion.
Cash & Marketable SecuritiesCHF521.40M
Total DebtCHF316.20M
Net CashCHF205.20M
Net Cash Per ShareCHF10.00T>
Tangible Book Value Per ShareCHF42.30
Margins
Gross margin is 36.24%, with operating margin of 20.09%, and net profit margin of 16.06%.
Gross Margin36.24%
Operating Margin20.09%
Pretax Margin20.02%
Net Profit Margin16.06%
EBITDA Margin23.54%
EBIT Margin19.49%
Analyst Forecast
The average price target for West Pharmaceutical Services is CHF297.41, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price TargetCHF297.41
Price Target Upside― Downside
Analyst ConsensusStrong Buy
Analyst Count8
Revenue Growth Forecast―
EPS Growth Forecast―